Dr. Roshni Thakkar is a Research Assistant Professor in the Department of Neurology, Miller School of Medicine, University of Miami, Miami FL. Her primary areas of research include gender differences, neuroinflammation, and cognition, in stroke and other neurodegenerative as well as psychiatric disorders. Dr. Thakkar is currently working on developing stroke therapies, including, but not limited to, use of stem cells in stroke. Dr. Thakkar received her PhD in Neuroscience (with distinction) from the Medical College of Georgia (MCG) at Augusta University in Augusta, Georgia, USA. During her PhD, she published novel findings on the anti-inflammatory and neuroprotective role of the hormone, estrogen in the brain in pre-clinical models of brain ischemia. While at MCG, Dr. Thakkar received the Brann Neuroscience Scholarship and the Brann Alumni Award for outstanding Neuroscience graduate student. Dr. Thakkar then pursued a post-doctoral research fellowship at the University of Tennessee Medical Center, Knoxville, TN. During her post-doctoral training, Dr. Thakkar examined the neurobiology of memory and cognition with relation to steroidal hormones and inflammation using genetically modified pre-clinical models. She also served as a scientist on the team of clinicians to develop clinical research. Dr. Thakkar has a diverse background ranging from molecular neurobiology, in vitro models, pre-clinical in vivo models to designing clinical studies. Dr. Thakkar has published press release research articles, review articles, invited book chapters and has been an invited speaker at several international meetings and institutes. She has a passion for teaching which is reflected in her broad teaching experiences at various levels, including high school, undergraduate as well as graduate level. Dr. Thakkar always welcomes the opportunity to collaborate with colleagues around the world and work with students, while sharing her knowledge to achieve the common goal of advancing biomedicine.

Dr. Roshni Thakkar's research interests are Stem cell therapy for stroke and vascular cognitive impairments with a focus on neuroinflammation and gender differences.